Celontin

Methsuximide

Mesuximide (or methsuximide, methosuximide) is a succinimide anticonvulsant medication. It is sold as a racemate by Pfizer under the tradenames Petinutin (Switzerland)[1] and Celontin (United States).[2] The therapeutic efficacy of methosuximide is largely due to its pharmacologically active metabolite, N-desmethylmethosuximide, which has a longer half-life and attains much higher plasma levels than its parent.[3] Medical use is indicated for...

Drug Index

Mesuximide (or methsuximide, methosuximide) is a succinimide anticonvulsant medication. It is sold as a racemate by Pfizer under the tradenames Petinutin (Switzerland)[1] and Celontin (United States).[2] The therapeutic efficacy of methosuximide is largely due to its pharmacologically active metabolite, N-desmethylmethosuximide, which has a longer half-life and attains much higher plasma levels than its parent.[3] Medical use is indicated for...

NDC Database

Celontin 300 mg Oral Capsule by Parke-davis Div of Pfizer Inc ## Markings: 300;mg;PD525 ## Shape: Capsule ## Color: Yellow ## Package Codes: 0071-0525-24 ## Active Ingredients: Methsuximide

NDC Database

Celontin 300 mg Oral Capsule by Farmea ## Markings: 300;mg;PD525 ## Shape: Capsule ## Color: Yellow ## Package Codes: 24822-525-24 ## Active Ingredients: Methsuximide